InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by Sensenig Bethany, Director. Officer active across 1 companies, notably Supernus Pharmaceuticals, INC.. Aggregated, 4 reports have been published. Total volume traded: €389k. The latest transaction was disclosed on 19 February 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
04,475 shares0
Common Stock
SEC:0001899935-26-000005·
04,475 shares0
Common Stock
SEC:0001899935-26-000005:0·
US$194,6905,369 shares@ US$36.26190.0068% mcap100.0% of flow
Common Stock
SEC:0001628280-25-040668·
€194,6905,369 shares@ €36.26190.0068% mcap50.0% of flow
Common Stock
SEC:0001628280-25-040668:0·
4 of 4 declarations
About Sensenig Bethany
Bethany Sensenig is a Board Member at Supernus Pharmaceuticals, Inc. She brings expertise in corporate governance and strategy. Her role involves overseeing operations and contributing to strategic decision-making within the company. Through her experience, she plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.
